![]() |
![]() |
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Division Faculty Medical School: St. Louis University School of Medicine, St. Louis, MO (1985) Residency: University of Michigan Hospitals Fellowship: Gastroenterology, The Johns Hopkins University Transplantation Hepatology, The Johns Hopkins University Board Certification: American Board of Internal Medicine American Board of Internal Medicine, Gastroenterology Clinical Interests: Hepatology. Research Interests: Differences in HCV response to therapy between Caucasians and African-Americans. Selected Publications: 1. Fleckenstein JF, Frank S, Thuluvath PJ. 1996. Presence of autonomic neuropathy is a poor prognostic indicator in patients with advanced liver disease. Hepatology 23(3): 471-5. 2.
Fleckenstein JF, Paredes M, Thuluvath PJ. 1998. A prospective,
randomized, double-blind trial evaluating the efficacy of ursodeoxycholic
acid in prevention of liver transplant rejection.
4.
Di Bisceglie AM, Lyra AC, Schwartz M, Reddy RK, Martin P, Gores G, Lok
AS, Hussain KB, Gish R, Van Thiel DH, Younossi Z, Tong M, Hassanein T,
Balart L, Fleckenstein J, Flamm S, Blei A, Befeler AS; Liver Cancer Network.
2003. Hepatitis C-related hepatocellular carcinoma in the United
States: influence of ethnic status. Am J Gastroenterol. 98(9): 2060-3.
5. Fleckenstein, J. 2004.
Chronic hepatitis C in african americans and other minority groups. Book Chapters: Fleckenstein J, Diehl AM: Complications of Chronic Liver Disease In Current Diagnosis and Treatment in Gastroenterology, Grendell, McQuaid and Friedman, editors, Stamford, CT, 1996, pp. 558-570.
|
|||||||||||||||||||||||||||||||||||||||||||||||
| Copyright ©2003 The University of Tennessee Health Science Center · Memphis, Tennessee 38163 · Telephone 901-448-5500 | |